Search research articles
Contact Us
Filters
Showing results (51-60 of 158) with videos related to
Page
of 16
Sort By:
Leukemia Research
|
August 22, 2015
Updated recommendations on the management of gastrointestinal disturbances during iron chelation therapy with Deferasirox in transfusion dependent patients with myelodysplastic syndrome - Emphasis on optimized dosing schedules and new formulations
Florian Nolte, Emanuele Angelucci, Massimo Breccia, et al.
Leukemia Research
|
June 29, 2011
Incidence and prevalence of myelodysplastic syndromes: data from the Düsseldorf MDS-registry
Judith Neukirchen, Wilma M Schoonen, Corinna Strupp, et al.
European Journal of Haematology
|
May 20, 2018
Effect of deferasirox + erythropoietin vs erythropoietin on erythroid response in Low/Int-1-risk MDS patients: Results of the phase II KALLISTO trial
Norbert Gattermann, Rosa Coll, Lutz Jacobasch, et al.
Leukemia Research
|
February 3, 2009
Impact on survival of different treatments for myelodysplastic syndromes (MDS)
Kathrin Nachtkamp, Andrea Kündgen, Corinna Strupp, et al.
Blood
|
January 25, 2007
High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count>600x109/L) and ringed sideroblasts more than 15% considered as MDS/MPD, unclassifiable
Norbert Gattermann, Johan Billiet, Ralf Kronenwett, et al.
Leukemia Research
|
May 9, 2012
Improved survival in MDS patients receiving iron chelation therapy - a matched pair analysis of 188 patients from the Düsseldorf MDS registry
Judith Neukirchen, Frank Fox, Andrea Kündgen, et al.
Haematologica
|
April 2, 2009
The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome
Esther Zipperer, Daniela Pelz, Kathrin Nachtkamp, et al.
Blood
|
May 25, 2004
Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid
Andrea Kuendgen, Corinna Strupp, Manuel Aivado, et al.
International Journal of Laboratory Hematology
|
January 29, 2024
Validation of a novel algorithm with a high specificity in ruling out MDS
Felicitas Schulz, Kathrin Nachtkamp, Howard S Oster, et al.
Annals of Hematology
|
July 12, 2013
Serum hepcidin measured with an improved ELISA correlates with parameters of iron metabolism in patients with myelodysplastic syndrome
Esther Zipperer, Jochen G Post, Matthias Herkert, et al.
Page
of 16
Search research articles
Search
Showing results (51-60 of 158) with videos related to
Sort By:
Page
of 16
Leukemia Research
|
August 22, 2015
Updated recommendations on the management of gastrointestinal disturbances during iron chelation therapy with Deferasirox in transfusion dependent patients with myelodysplastic syndrome - Emphasis on optimized dosing schedules and new formulations
Florian Nolte, Emanuele Angelucci, Massimo Breccia, et al.
Leukemia Research
|
June 29, 2011
Incidence and prevalence of myelodysplastic syndromes: data from the Düsseldorf MDS-registry
Judith Neukirchen, Wilma M Schoonen, Corinna Strupp, et al.
European Journal of Haematology
|
May 20, 2018
Effect of deferasirox + erythropoietin vs erythropoietin on erythroid response in Low/Int-1-risk MDS patients: Results of the phase II KALLISTO trial
Norbert Gattermann, Rosa Coll, Lutz Jacobasch, et al.
Leukemia Research
|
February 3, 2009
Impact on survival of different treatments for myelodysplastic syndromes (MDS)
Kathrin Nachtkamp, Andrea Kündgen, Corinna Strupp, et al.
Blood
|
January 25, 2007
High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count>600x109/L) and ringed sideroblasts more than 15% considered as MDS/MPD, unclassifiable
Norbert Gattermann, Johan Billiet, Ralf Kronenwett, et al.
Leukemia Research
|
May 9, 2012
Improved survival in MDS patients receiving iron chelation therapy - a matched pair analysis of 188 patients from the Düsseldorf MDS registry
Judith Neukirchen, Frank Fox, Andrea Kündgen, et al.
Haematologica
|
April 2, 2009
The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome
Esther Zipperer, Daniela Pelz, Kathrin Nachtkamp, et al.
Blood
|
May 25, 2004
Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid
Andrea Kuendgen, Corinna Strupp, Manuel Aivado, et al.
International Journal of Laboratory Hematology
|
January 29, 2024
Validation of a novel algorithm with a high specificity in ruling out MDS
Felicitas Schulz, Kathrin Nachtkamp, Howard S Oster, et al.
Annals of Hematology
|
July 12, 2013
Serum hepcidin measured with an improved ELISA correlates with parameters of iron metabolism in patients with myelodysplastic syndrome
Esther Zipperer, Jochen G Post, Matthias Herkert, et al.
Page
of 16